Dhiraj Dhoot

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Socioeconomic status, disease duration, and DLQI scores in adults with moderate-to-severe atopic dermatitis: A multicenter cross-sectional study.

Socioeconomic status, disease duration, and DLQI scores in adults with moderate-to-severe atopic dermatitis: A multicenter cross-sectional study.

Journal: JAAD international

Published: June 22, 2026

Real-World Evaluation of the Episoft® AC Moisturizer With Broad-Spectrum Sunscreen in the Management of Retinoid-Induced Dermatitis: A Retrospective Observational Study.

Real-World Evaluation of the Episoft® AC Moisturizer With Broad-Spectrum Sunscreen in the Management of Retinoid-Induced Dermatitis: A Retrospective Observational Study.

Journal: Cureus

Published: May 09, 2026

Assessing the Impact of Dermatophytosis on Quality of Life Using the Dermatology Life Quality Index: A Real-World Cross-Sectional Study From India.

Assessing the Impact of Dermatophytosis on Quality of Life Using the Dermatology Life Quality Index: A Real-World Cross-Sectional Study From India.

Journal: Cureus

Published: March 31, 2026

The Atopic Dermatitis Patient Journey: From Awareness to Advanced Care.

The Atopic Dermatitis Patient Journey: From Awareness to Advanced Care.

Journal: Cureus

Published: January 29, 2026

PROMISE‑MINO: A Prospective, Open‑Label, Multicenter, Single‑Arm, Phase IV Study of the Safety, Local Tolerability, and Efficacy of Topical Minocycline Hydrochloride 4% Gel in Indian Patients With Moderate‑to‑Severe Acne Vulgaris.

PROMISE‑MINO: A Prospective, Open‑Label, Multicenter, Single‑Arm, Phase IV Study of the Safety, Local Tolerability, and Efficacy of Topical Minocycline Hydrochloride 4% Gel in Indian Patients With Moderate‑to‑Severe Acne Vulgaris.

Journal: Cureus

Published: January 15, 2026

Enhanced follicular delivery of minoxidil to human scalp skin using cetosomal formulation.

Enhanced follicular delivery of minoxidil to human scalp skin using cetosomal formulation.

Journal: Colloids and surfaces. B, Biointerfaces

Published: January 07, 2026

PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India-A Modified Delphi Consensus.

PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India-A Modified Delphi Consensus.

Journal: Antibiotics (Basel, Switzerland)

Published: July 03, 2025

Practical Recommendations for Indians on Sunscreen Use-A Modified Delphi Consensus by Indian Sunscreen Forum (PRISM-ISF).

Practical Recommendations for Indians on Sunscreen Use-A Modified Delphi Consensus by Indian Sunscreen Forum (PRISM-ISF).

Journal: Journal of cosmetic dermatology

Published: June 17, 2025

Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females.

Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females.

Journal: Cureus

Published: March 28, 2025

A Comparative, Multicenter, Prospective, Randomized Study to Evaluate the Efficacy, Safety, and Delay of Relapse of Ceramide-Based Post-biotic Moisturizer Versus Paraffin-Based Moisturizer in Mild to Moderate Atopic Dermatitis.

A Comparative, Multicenter, Prospective, Randomized Study to Evaluate the Efficacy, Safety, and Delay of Relapse of Ceramide-Based Post-biotic Moisturizer Versus Paraffin-Based Moisturizer in Mild to Moderate Atopic Dermatitis.

Journal: Cureus

Published: January 01, 2025

A prospective, randomised comparative study to evaluate safety, tolerability, and efficacy of topical minocycline gel 4% plus oral isotretinoin against oral isotretinoin only in Indian patients with moderate-to-severe acne vulgaris.

A prospective, randomised comparative study to evaluate safety, tolerability, and efficacy of topical minocycline gel 4% plus oral isotretinoin against oral isotretinoin only in Indian patients with moderate-to-severe acne vulgaris.

Journal: Postepy dermatologii i alergologii

Published: October 14, 2024

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose.

Real-World Indian Experience of Switchover to Bilastine 40 mg/day in CSU Patient Refractory to Other Antihistamines at Double Dose.

Journal: Indian journal of dermatology

Published: February 19, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026